To examine the prevalence of cryoglobulinaemia in patients with chronic hepatitis C infection and its relation to extrahepatic neuro-cutaneous manifestations. Methods Forty patients (26 males & 14 females), with clinical, laboratory and histologically established chronic hepatitis C infection, with a mean age of 37.5 years, were submitted to clinical examination, dermatological and neurological evaluation. Neuroimaging as well as neurophysiological evaluation, laboratory assessment including liver function tests, serum cryoprecipitate immunoelectrophoresis, and revision of histopathlogical findings were performed. Results A high prevalence of cryglobulenemia: 62.5% in patients with chronic hepatitis C infection, the presenting symptoms were fatigue (67.5%), arthralgia (32.5%), paresthesia (30%) and pruritus (25%); however, there were no statistically significant difference between cryo +ve versus cryo -ve patients except for pruritis, and face pigmentation. Skin manifestations including face pigmentation (42.5%), leukocytoclastic vasculitis (22.5%), porphyria cutanea tarda (20%), lichen planus (17.5%), acral necrolytic erythema (15%) and vitiligo (15%). Neurological manifestations ; symptomatic neuropathy in 10%, neuropathic changes in 30% and electroencephalographic changes in 22.5%. These cutaneous and neurological manifestations were significantly associated with the presence of cryoglobulinaemia. Conclusion Our findings support an association between cryoglobuliaemia and extrahepatic neurocutaneous manifestations of hepatitis C infection. The presence of all these manifestations in the appropriate clinical setting should suggest the presence of hepatitis C infection.
Introduction
owadays, there is an increasing awareness of a variety of extrahepatic syndromes that seem to be associated with HCV infection 1 . Pascual et al 2 reported two patients with chronic HCV infection and essential mixed cryoglobulinaemia (EMC). Since then, a considerable number of extrahepatic syndromes has been reported as described by Nocente et al 3 . Cryoglobulinaemia (Cg) is a condition characterized by the presence of serum proteins that reversibly precipitate in cold 4 and are classified on the basis of their immunoglobulin composition according to Brouet et al 5 . The clinical manifestations of mixed cryoglobulinaemia (MC) range from asymptomatic, mild vasculitis with palpable purpura, arthralgia and fatigue, to severe vasculitis with skin necrosis 6 , involvement of the kidneys 7 , peripheral nerves 8 , and centeral nervous system 9 . Fifty percent of patients with chronic HCV, show detectable cryoglobulinaemia, even though most of them do not show cryoglobulinaemia related symptom 10 . Factors involved in the production of Cg in HCV infected patients are unknown; most likely the presence of HCV in the cells of the immune system and /or chronic stimulation of the immune response by HCV. Also, genetic factors may be involved in the pathogenesis of Cg. Little is known about the clinical significance of Cg in the course of chronic HCV 11 . Neurological manifestations of HCV have been less well characterized and reported, including peripheral nerve vasculitic neuropathy, and also intracranial vasculopathy 12, 13 . Peripheral neuropathy is present in most of the patients with symptomatic cryoglobulinaemia where it may be the first clinical manifestations 10 . In 1998, Origgi and Colleagues 14 , described 3 patients who complained of mild CNS problems, including confusion and disequilibrium and magnatic resonance imaging (MRI) of these patients showed small hyperintensities consistant with ischaemic lesions. In Heckmann et al 9 . review of a small series of HCV-infected   patients  showing  neurological  manifestations, a patient with systemic  vasculitis  associated  with  systemic  cryoglobulinaemia is described who progressed from apathy to severe drowsiness with myoclonic jerks and multiple pyramidal tract signs and MRI showed increased prolonged Spin echo signal diffusely throughout the deep white matter that resemble HIV-associated leukoencephalopathy. Chronic HCV is associated with and may trigger or exacerbate an extraordinary variety of extrahepatic skin manifestations, the most frequent and important of which are the leukocytoclastic vasculitis (LCV) of mixed cryoglobulinaemia type 2 and porphyria cutinea tarda (PCT) 15 . Cutaneous symptoms relevant to HCV infection manifest in 20 -40 % of patients presenting to dermatologists and in a significant percentage (15 -20 %) of general patients and HCV are suggested and must appear in the differential diagnosis of these patients to avoid missing this important but occult factor in clinical disease in the appropriate setting 16 . Leukocytoclastic vasculitis (LCV) due to cryoglobulinaemia is a good example of a specific skin manifestation resulting from the production of immunoglobulins with rheumatoid factor characteristics causing an immune complex-mediated vasculitis while Porpheria cutanea tarda (PCT) is a good example of HCV-related disease in which causation is undeniable where 70 % of patients with PCT have HCV 16 . The objective of this work was to determine the prevalence of Cg in our patients with chronic HCV infection and its relation to the neuro-cutaneous extrahepatic manifestations.
Materials and Methods
Forty patients (26 males and 14 females), with established diagnosis of chronic HCV (clinical, laboratory and histopathological), with a mean age of 37.5 years were studied. Exclusion criteria were the following: 1. Chronic hepatitis C patients with Fibrosis score ( F ) 
Detection of Cryoglobulins
The thermolability of cryoglobulins necessitated that the blood samples be collected at 37°C. Syringes and collection tubes were at 37°C at the time of blood collection and maintained at 37°C until clotting is completed. Tubes for collection were not anticoagulated, since the use of plasma may result in the development of cold-precipitable fibrinogen (cryofibrinogen) or heparin-precipitable protein. Blood Sampling10mL of blood in a warm syringe (37°C) were collected. Analysis Process: A white precipitate (cryoglobulin) appeared in the serum after 24-72 hours of storage at 4°C.
The serum was tested for the reversibility of the cryoprecipitate by rewarming an aliquot at 37°C for 24 hours.
The cryocrit was estimated by measuring the height of the column of precipitated protein relative to the height of the serum column 17 . Liver histology was evaluated according to the standard international criteria using Metavir Score (Table 1) .
Statistical Methods
Frequency, mean, standard deviation and standard error of mean were used to describe data. Mann-Whitney test was used to test for significance of difference in quantitative variables between each two groups. Chi-square test was used to test for association between groups and clinical categorical data. P value was considered significant if < 0.05. These tests were run on an IBM compatible personal computer using the Statistical Package for Social scientists (SPSS) for windows 7.5 (SPSS Inc, Chicago, IL, USA). The study protocol was approved by human ethics committee of Specialized Medical Hospital Mansoura University. As regard to laboratory findings including liver function tests (SGPT, serum bilirubin and prothrombin time), urine analysis (for proteinuria), serum creatinine, ANA, RF and quantitative PCR for HCV-RNA, there were no statistically significant difference between cryo +ve and cryo -ve patients except for proteinuria. Concerning the liver histopathological findings (evaluated according to Metavir score) there were no statistically significant difference in activity score between cryo +ve versus cryo -ve patients.
Results
The results are shown in Tables 2-5. 
5%). Leukocytoclastic vasculitis was the main skin lesion 9 cases(22.5%) followed by porphyria cutenia tarda 8 cases (20%) and Lichen planus 7 cases (17.5%). Symptomatic neuropathy was only found in 4 cases (10%) while in 12 cases (30%) neuropathy was detected by nerve conduction velocity and EMG. EEG changes were detected in 9 cases (22.5%).

Discussion
The present study demonstrated a high prevalence of Cg: 62.5% in patients with chronic HCV infection. Different studies showed wide variation from 19% -57% 
